SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024077
Filing Date
2019-06-28
Accepted
2019-06-28 16:35:53
Documents
5
Period of Report
2019-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20190625.htm 8-K 33095
2 EX-1.1 ODONATE THERAPEUTICS, INC. COMMON STOCK UNDERWRITING AGREEMENT odt-ex11_26.htm EX-1.1 200765
3 EX-5.1 OPINION OF GIBSON, DUNN & CRUTCHER LLP odt-ex51_27.htm EX-5.1 7244
4 GRAPHIC g0ugxnqdxx33000002.jpg GRAPHIC 30438
5 GRAPHIC g0ugxnqdxx33000001.jpg GRAPHIC 89690
  Complete submission text file 0001564590-19-024077.txt   408079
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 19929897
SIC: 2834 Pharmaceutical Preparations